shu-508 and Cystadenocarcinoma

In this report, we showed the efficacy of a new contrast agent (SH/TA-508, Schering AG, Germany) for color Doppler imaging of the pancreatic tumors. In pancreatic ductal cancer, no enhancement of the lesion was observed, but vascular invasion by cancer became to be easily evaluated. On the other hand, hypervascular tumors such as islet cell tumor and cystadenocarcinoma, were increased in color Doppler signals of vessels by SH/TA-508. We concluded that SH/TA-508 was useful for evaluating the vascular invasion by pancreatic cancer as well as vascularity of hypervascular mass and solid component of cystic neoplasma.

Topics: Adenoma, Islet Cell; Aged; Contrast Media; Cystadenocarcinoma; Female; Humans; Image Enhancement; Male; Middle Aged; Pancreatic Neoplasms; Polysaccharides; Ultrasonography, Doppler, Color